CLINICAL SCIENCE

Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study

Gerasimos Anastassiou¹, Arnd Heiligenhaus², Nikos Bechrakis³, Elisabeth Bader¹, Norbert Bornfeld¹ and Klaus-Peter Steuhl¹

¹ Department of Ophthalmology, University Hospital Essen, University of Essen, Germany
² Department of Ophthalmology, St Franziskus Hospital, Muenster, Germany
³ Department of Ophthalmology, UKBF, Free University, Berlin, Germany

Correspondence to:
Correspondence to:
Dr G Anastassiou, Department of Ophthalmology, University of Essen, Hufelandstrasse 55, D-45122 Essen, Germany;
gerasimos.anastassion{at}uni-essen.de

Aim: To determine prognostic factors for recurrence of disease and tumour related mortality in patients with conjunctival melanoma.

Methods: A retrospective analysis of clinical and histopathological data of 69 patients with histologically verified conjunctival melanoma.

Results: As univariate analysis showed, significant risk factors for the development of recurrence were: irregular pigmentation (RR = 2.0, p = 0.0007), incomplete surgical excision (RR = 3.5, p = 0.008), tumour invasion deeper than in substantia propria (RR = 3.9, p = 0.008), and presence of epithelioid tumour cells (RR = 2.9, p = 0.05). For tumour related mortality a significantly increased risk was found for tumour location in palpebral conjunctiva, caruncle, plica, or fornices (RR = 5.9, p = 0.001), for tumour infiltration deeper than the substantia propria (RR = 5.5, p = 0.001), for incomplete surgical excision (RR = 4.4, p = 0.05), and for nodular or mixed (nodular and superficial) growth pattern of the tumours (RR = 1.2, p = 0.002). The use of an adjuvant therapy for the surgical excision of the melanomas had no statistically significant influence upon the development of recurrent disease nor upon the tumour related mortality.

Conclusion: These data present similar clinical and histopathological risk factors for patients with conjunctival melanoma as reported previously. The present study also addresses the failure of retrospective studies on conjunctival melanoma to prove the efficacy of a supplementary therapy to surgical excision.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Cunneen, T. S., Conway, R. M., Madigan, M. C. (2009). In Vitro Effects of Histone Deacetylase Inhibitors and Mitomycin C on Tenon Capsule Fibroblasts and Conjunctival Melanoma Cells. Arch Ophthalmol 127: 414-420 [Abstract] [Full Text]  
• Damato, B, Coupland, S E (2008). Clinical mapping of conjunctival melanomas. Br. J. Ophthalmol. 92: 1545-1549 [Abstract] [Full Text]  
• Lim, M, Tatla, T, Hersh, D, Hungerford, J (2006). Patterns of regional head and neck lymph node metastasis in primary conjunctival malignant melanoma. Br. J. Ophthalmol. 90: 1468-1471 [Abstract] [Full Text]  
• Missotten, G. S., Keijser, S., De Keizer, R. J. W., De Wolff-Rouendaal, D. (2005). Conjunctival Melanoma in The Netherlands: A Nationwide Study. IOVS 46: 75-82 [Abstract] [Full Text]  
• Gear, H., Williams, H., Kemp, E. G., Roberts, F. (2004). BRAF Mutations in Conjunctival Melanoma. IOVS 45: 2484-2488 [Abstract] [Full Text]